Clinical Trial Update: Chemotherapy, Radiation Therapy, and Cetuximab in Treating Patients With the Head and Neck Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the combination of chemotherapy, radiation therapy, and cetuximab for head and neck cancer has completed. The update indicat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Drugs mentioned

• ERBITUX (cetuximab)

Snippet

Sponsor: Centre Antoine Lacassagne | Conditions: Head and Neck Cancer | Phase 2 | Status: COMPLETED